[Studies on nifedipine, a coronary vasodilator agent with rapid sublingual effects].
D000042:Absorption; D000284:Administration, Oral; D000818:Animals; D003326:Coronary Circulation; D003331:Coronary Vessels / Q000187:drug effects*; D003998:Dicarboxylic Acids / Q000008:administration & dosage / Q000494:pharmacology; D004285:Dogs; D006168:Guinea Pigs; D006321:Heart / Q000187:drug effects; D006439:Hemodynamics / Q000187:drug effects; D007275:Injections, Intravenous; D009060:Mouth Floor; D009578:Nitrobenzenes / Q000008:administration & dosage / Q000494:pharmacology*; D010100:Oxygen / Q000097:blood; D011725:Pyridines / Q000008:administration & dosage / Q000494:pharmacology*; D012119:Respiration / Q000187:drug effects; D014665:Vasodilator Agents / Q000008:administration & dosage / Q000494:pharmacology*
D003998:Dicarboxylic Acids; D009578:Nitrobenzenes; D011725:Pyridines; D014665:Vasodilator Agents; D010100:Oxygen
Untersuchungen mit Nifedipine, einer coronargefässerweiternden Substanz mit schneller sublingualer Wirkung.